Loading…
Akso Health Group is projected to rise to $1.79 by 2027, a +14% move from its current price of $1.57. AHG is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $1.51 | $1.57 | $1.63 | 0.00% |
| Aug 3 | $1.49 | $1.57 | $1.66 | -0.01% |
| Aug 4 | $1.47 | $1.57 | $1.68 | -0.01% |
| Aug 5 | $1.46 | $1.57 | $1.69 | -0.01% |
| Aug 6 | $1.44 | $1.57 | $1.71 | -0.02% |
| Aug 7 | $1.43 | $1.57 | $1.72 | -0.02% |
| Aug 8 | $1.42 | $1.57 | $1.73 | -0.02% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.42 | $1.57 | $1.73 | -0.02% |
| Week 2 | $1.36 | $1.57 | $1.81 | -0.04% |
| Week 3 | $1.32 | $1.57 | $1.86 | -0.07% |
| Week 4 | $1.28 | $1.57 | $1.91 | -0.09% |
| Week 5 | $1.25 | $1.57 | $1.96 | -0.11% |
| Week 6 | $1.23 | $1.57 | $2.00 | -0.13% |
| Week 7 | $1.20 | $1.57 | $2.04 | -0.16% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Akso Health Group (AHG) is a healthcare company that operates a social e-commerce mobile platform in the People’s Republic of China through Xiaobai Maimai App. The platform offers a wide range of products including food and beverage, wine, cosmetics, fashion and apparel, entertainment, housewares, home appliances, and cost-saving promotions at petrol gas stations. The group also sells medical devices such as defibrillators and anesthesia laryngoscopes, and provides health treatment, consultancy support, and marketing promotion services, as well as trading and technological promotion services and import and export.
It was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was incorporated in 2016 and is headquartered in Qingdao.
Akso Health Group is a healthcare-focused entity trading on the public market with a current price of $1.59 and a market capitalization of $1.36B. It occupies a position within the healthcare category and combines e-commerce with health-oriented devices and services.
As of now, AHG holds a market rank of 2164. The longer-term price outlook is constructive, with the forecast showing an ascent in average price to $2.80 by 2030 and potential highs up to $4.41 by 2030, and a much higher trajectory by 2050, where the average price is projected to $9.41 and the max to $20.12. These figures reflect a sustained bullish tilt over the multi-year horizon.
A major floor 26.1% below — a decisive break under it would weaken the trend.
The nearest floor, 14.6% below — buyers have tended to step in here.
Price is pressing into resistance (1.9% away) — a breakout level to watch.
A major ceiling 56.1% above — clearing it would confirm fresh momentum.
Key AHG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AHG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.51 | Buy | $1.53 | Buy |
| MA 10 | $1.51 | Buy | $1.52 | Buy |
| MA 20 | $1.52 | Buy | $1.51 | Buy |
| MA 50 | $1.46 | Buy | $1.55 | Buy |
| MA 100 | $1.82 | Sell | $1.63 | Sell |
| MA 200 | $1.65 | Sell | $1.63 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.91 | Neutral |
| Stoch RSI (14) | 80.93 | Sell |
| CCI (20) | 76.72 | Neutral |
| Williams %R (14) | -18.75 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 2.61 | Buy |
| Bollinger %B (20,2) | 0.74 | Neutral |
| Stochastic %K (14) | 81.25 | Sell |
| TRIX (15) | 0.08 | Buy |
| Awesome (5,34) | 0.05 | Buy |
| Ultimate (7,14,28) | 67.03 | Neutral |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 1.54 | Buy |
| ADX (14) | 10.97 | Neutral |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is bullish, with RSI14 at 60 and trend bearings supported by the moving-average setup: SMA50 at $1.46 and SMA200 at $1.65. The current momentum aligns with a constructive near-term stance.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.16 | $1.57 | $2.16 | 0% | Neutral | |
| $1.38 | $1.79 | $2.49 | +14% | Neutral | |
| $1.49 | $2.02 | $2.95 | +29% | Bullish | |
| $1.71 | $2.39 | $3.62 | +52% | Bullish | |
| $1.89 | $2.72 | $4.25 | +73% | Bullish | |
| $1.75 | $2.60 | $4.18 | +66% | Bullish | |
| $1.68 | $2.56 | $4.22 | +63% | Bullish | |
| $1.71 | $2.66 | $4.48 | +70% | Bullish | |
| $1.68 | $2.68 | $4.60 | +71% | Bullish | |
| $2.14 | $3.50 | $6.12 | +123% | Bullish | |
| $2.04 | $3.71 | $7.02 | +136% | Bullish | |
| $4.10 | $9.02 | $19.02 | +474% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.16 | $1.57 | $1.93 | +0.00% |
| September 2026 | $1.35 | $1.62 | $2.00 | +2.88% |
| October 2026 | $1.30 | $1.57 | $1.97 | -3.08% |
| November 2026 | $1.30 | $1.58 | $2.00 | +0.72% |
| December 2026 | $1.37 | $1.68 | $2.16 | +6.56% |
Click any year to see its month-by-month AHG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AHG to range from $1.16 to $2.16 through 2026. The $1.57 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The AHG price prediction for 2027 points to an average of $1.79 (low $1.38, high $2.49) — a potential gain of +14% on today's $1.57. Price action looks broadly range-bound.
In 2028, AHG is projected to trade between $1.49 and $2.95, averaging $2.02 — a potential gain of +29% from today's $1.57. That is up +13% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Akso Health Group's 2029 outlook centres on $2.39, within a $1.71 to $3.62 range. That is up +18% on the projected 2028 average. That marks a +52% change versus current levels. Momentum favours further upside here.
By 2030, AHG could reach as high as $4.25, with a base case around $2.72 and support toward $1.89 — roughly +73% from $1.57. Buyers look set to stay in control over this stretch.
Expect AHG to range from $1.75 to $4.18 through 2031. The $2.60 average target implies a +66% move from current prices. That is -4% versus the projected 2030 average. Momentum favours further upside here.
The AHG price prediction for 2032 points to an average of $2.56 (low $1.68, high $4.22) — a potential gain of +63% on today's $1.57. Buyers look set to stay in control over this stretch.
In 2033, AHG is projected to trade between $1.71 and $4.48, averaging $2.66 — a potential gain of +70% from today's $1.57. That is up +4% on the projected 2032 average. Momentum favours further upside here.
Akso Health Group's 2034 outlook centres on $2.68, within a $1.68 to $4.60 range. That is up +1% on the projected 2033 average. That marks a +71% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, AHG could reach as high as $6.12, with a base case around $3.50 and support toward $2.14 — roughly +123% from $1.57. Momentum favours further upside here.
Expect AHG to range from $2.04 to $7.02 through 2040. The $3.71 average target implies a +136% move from current prices. That is up +6% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The AHG price prediction for 2050 points to an average of $9.02 (low $4.10, high $19.02) — a potential gain of +474% on today's $1.57. Momentum favours further upside here.
Investing $1,000 in AHG today (≈ 636.942675 AHG) could be worth
$5,744.34
+$4,744.34 (+474%) by 2050 · US Dollar
Based on the average projected AHG price of $9.02 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AHGwould be worth at today's price.
$1,000 invested in AHG on Jul 31, 2025 (≈ 588.581518 AHG) would be worth
$924.07
-$75.93 (-7.6%) today · 0.92× · US Dollar
Based on a AHG entry price of $1.7 vs. today's $1.57.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.51 | $1,039.74 | +4.0% |
| 1 month ago | $1.51 | $1,039.74 | +4.0% |
| 3 months ago | $2.14 | $733.64 | -26.6% |
| 6 months ago | $1.47 | $1,068.03 | +6.8% |
| 1 year ago | $1.7 | $924.07 | -7.6% |
| All time (5.0y) ago | $1.63 | $963.19 | -3.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AHG forecast.
Our base-case forecast reaches $3.10 around 2035.
Implied market cap at $3.10: $2.65B
The forecasted path shows a steady rise in value across the coming years. In 2026 the average price is $1.59 with a neutral sentiment and 0% ROI. By 2027 the average price is projected at $1.82 with a 14.6% ROI and neutral sentiment, followed by a bullish trajectory through 2028 (avg $2.07, ROI 30.4%), 2029 (avg $2.46, ROI 54.8%), and 2030 (avg $2.80, ROI 75.9%), with a max of $4.41 and continued bullish momentum into the early 2030s.
Tap a question to reveal the answer.
Avg $2.80; min $1.92; max $4.41; ROI 75.9%; sentiment bullish.
The forecast shows a bullish path with averages rising from $1.59 in 2026 to $9.41 by 2050 and a max of $20.12 by 2050 (ROI 492%). These are estimates, not guarantees.
Yes. The 2050 max is $20.12, with an average of $9.41 and ROI 492%.
$1.59 per share.
Low $1.23, high $2.05.
Akso Health Group Community Discussion
0Share your Akso Health Group price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.